4//SEC Filing
Moses Alan Charles 4
Accession 0001178913-23-001115
CIK 0001534248other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 7:38 AM ET
Size
10.8 KB
Accession
0001178913-23-001115
Insider Transaction Report
Form 4
Moses Alan Charles
Director
Transactions
- Award
Option to Purchase American Depositary Shares
2022-03-07+6,820→ 6,820 totalExercise: $3.53Exp: 2032-03-07→ American Depositary Shares (6,820 underlying) - Award
Option to Purchase American Depositary Shares
2021-04-19+11,884→ 11,884 totalExercise: $27.26Exp: 2031-04-19→ American Depositary Shares (11,884 underlying) - Award
Option to Purchase American Depositary Shares
2023-03-16+6,857→ 6,857 totalExercise: $1.62Exp: 2033-03-21→ American Depositary Shares (6,857 underlying)
Footnotes (5)
- [F1]These options vest and become exercisable in their entirety on March 16, 2024, subject to the Reporting Person's continued service. These options were granted as per the annual grant of options to directors.
- [F2]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F4]These options vested and became exercisable in their entirety on March 16, 2023. These options were granted as per the annual grant of options to directors.
- [F5]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
Documents
Issuer
Chemomab Therapeutics Ltd.
CIK 0001534248
Entity typeother
Related Parties
1- filerCIK 0001819501
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 7:38 AM ET
- Size
- 10.8 KB